Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry - PubMed (original) (raw)
Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry
Yuliya V Skorobogatko et al. Amino Acids. 2011 Mar.
Erratum in
- Amino Acids. 2012 Jun;42(6):2529. Adolf-Bergfoyle, Jared [corrected to Adolf-Bryfogle, Jared]
Abstract
Neuronal synaptic functional deficits are linked to impaired learning and memory in Alzheimer's disease (AD). We recently demonstrated that O-GlcNAc, a novel cytosolic and nuclear carbohydrate post-translational modification, is enriched at neuronal synapses and positively regulates synaptic plasticity linked to learning and memory in mice. Reduced levels of O-GlcNAc have been observed in AD, suggesting a possible link to deficits in synaptic plasticity. Using lectin enrichment and mass spectrometry, we mapped several human cortical synaptic O-GlcNAc modification sites. Overlap in patterns of O-GlcNAcation between mouse and human appears to be high, as previously mapped mouse synaptic O-GlcNAc sites in Bassoon, Piccolo, and tubulin polymerization promoting protein p25 were identified in human. Novel O-GlcNAc modification sites were identified on Mek2 and RPN13/ADRM1. Mek2 is a signaling component of the Erk 1/2 pathway involved in synaptic plasticity. RPN13 is a component of the proteasomal degradation pathway. The potential interplay of phosphorylation with mapped O-GlcNAc sites, and possible implication of those sites in synaptic plasticity in normal versus AD states is discussed. iTRAQ is a powerful differential isotopic quantitative approach in proteomics. Pulsed Q dissociation (PQD) is a recently introduced fragmentation strategy that enables detection of low mass iTRAQ reporter ions in ion trap mass spectrometry. We optimized LTQ ion trap settings for PQD-based iTRAQ quantitation and demonstrated its utility in O-GlcNAc site mapping. Using iTRAQ, abnormal synaptic expression levels of several proteins previously implicated in AD pathology were observed in addition to novel changes in synaptic specific protein expression including Synapsin II.
Similar articles
- A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation.
Graham ME, Thaysen-Andersen M, Bache N, Craft GE, Larsen MR, Packer NH, Robinson PJ. Graham ME, et al. J Proteome Res. 2011 Jun 3;10(6):2725-33. doi: 10.1021/pr1011153. Epub 2011 May 2. J Proteome Res. 2011. PMID: 21500857 - O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.
Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby DA, Schoepfer R, Burlingame AL. Vosseller K, et al. Mol Cell Proteomics. 2006 May;5(5):923-34. doi: 10.1074/mcp.T500040-MCP200. Epub 2006 Feb 1. Mol Cell Proteomics. 2006. PMID: 16452088 - Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
Yuzwa SA, Yadav AK, Skorobogatko Y, Clark T, Vosseller K, Vocadlo DJ. Yuzwa SA, et al. Amino Acids. 2011 Mar;40(3):857-68. doi: 10.1007/s00726-010-0705-1. Epub 2010 Aug 13. Amino Acids. 2011. PMID: 20706749 - Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
Whelan SA, Hart GW. Whelan SA, et al. Circ Res. 2003 Nov 28;93(11):1047-58. doi: 10.1161/01.RES.0000103190.20260.37. Circ Res. 2003. PMID: 14645135 Review. - Does O-GlcNAc play a role in neurodegenerative diseases?
Lefebvre T, Guinez C, Dehennaut V, Beseme-Dekeyser O, Morelle W, Michalski JC. Lefebvre T, et al. Expert Rev Proteomics. 2005 Apr;2(2):265-75. doi: 10.1586/14789450.2.2.265. Expert Rev Proteomics. 2005. PMID: 15892570 Review.
Cited by
- O-GlcNAcylation and neurodegeneration.
Wani WY, Chatham JC, Darley-Usmar V, McMahon LL, Zhang J. Wani WY, et al. Brain Res Bull. 2017 Jul;133:80-87. doi: 10.1016/j.brainresbull.2016.08.002. Epub 2016 Aug 4. Brain Res Bull. 2017. PMID: 27497832 Free PMC article. Review. - Detection and analysis of proteins modified by O-linked N-acetylglucosamine.
Zachara NE, Vosseller K, Hart GW. Zachara NE, et al. Curr Protoc Protein Sci. 2011 Nov;Chapter 12:12.8.1-12.8.33. doi: 10.1002/0471140864.ps1208s66. Curr Protoc Protein Sci. 2011. PMID: 22045558 Free PMC article. - Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M, Qiu Z, Zhang S, Fan X, Cai X, Xu B, Li X, Zhou J, Zhang X, Chu Y, Wang W, Liang J, Horvath T, Yang X, Wu K, Nie Y, Fan D. Jiang M, et al. Oncotarget. 2016 Sep 20;7(38):61390-61402. doi: 10.18632/oncotarget.11359. Oncotarget. 2016. PMID: 27542217 Free PMC article. - A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer.
Wang L. Wang L. Int J Gen Med. 2021 Dec 25;14:10337-10350. doi: 10.2147/IJGM.S332945. eCollection 2021. Int J Gen Med. 2021. PMID: 34992448 Free PMC article. - The use of biophysical proteomic techniques in advancing our understanding of diseases.
Xu Q, Cui Z, Venkatraman G, Gomes AV. Xu Q, et al. Biophys Rev. 2012 Jun;4(2):125-135. doi: 10.1007/s12551-012-0070-2. Epub 2012 Mar 15. Biophys Rev. 2012. PMID: 28510094 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous